Human prothrombin complex (Tonrol Biopharmaceuticals)

人凝血酶原复合物（同路生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman prothrombin complex (Tonrol Biopharmaceuticals)
Drug Alias Name凝血酶原复合体浓缩物 - 同路生物制药有限公司Human prothrombin complex (Shanghai RAAS)ProthoRAAS
ClassificationBiologics > Blood components
Mechanisms of ActionCoagulation factor VII modulatorsCoagulation factor X modulatorsCoagulation factor IX modulators +[4] 
TargetsCoagulation factor VIIProthrombinCoagulation factor IX +[4] 
Therapy Area/IndicationsHemorrhageHemophilia B
Global Approved IndicationsHemorrhage
Approved Indications in ChinaHemorrhage
Original Approved Country/TerritoryMainland China
Original Approved Date1996/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTonrol Bio-Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Raas Blood Products Co Ltd
Inactive CompaniesTonrol Bio-Pharmaceutical Co Ltd
Active IndicationsHemorrhageHemophilia B
Inactive IndicationsN/A

Other Information

ATC CodeB02BD01
Related LinksN/A